Identification of Ly2 members as antimicrobial peptides from zebrafish Danio rerio. Issue 1 (17th January 2017)

• Record Type: Journal Article
• Authors: Liu, Xuemin; Cao, Xuwen; Wang, Su; Ji, Guangdong; Zhang, Shicui; Li, Hongyan
• Is Part Of: Bioscience reports. Volume 37:Issue 1(2017)
• Publication Date: 2017-01-17
• Subjects: zebrafish Danio rerio -- Ly6 gene cluster -- Antimicrobial peptides; Molecular biology -- Periodicals; Cytology -- Periodicals; 572.8
• DOI: 10.1042/BSR20160265
• Languages: English
• ISSNs: 0144-8463

Abstract

Abstract : The emergence of multidrug-resistant (MDR) microbes caused by overuse of antibiotics leads to urgent demands for novel antibiotics exploration. Our recent data showed that Ly2.1–3 (a novel lymphocyte antigen 6 ( Ly6 ) gene cluster) were proteins with cationic nature and rich in cysteine content, that are characteristic of antimicrobial peptides (AMPs) and their expression were all significantly up-regulated after challenge with lipopolysaccharide (LPS). These strongly suggested that Ly2.1–3 are potential AMPs, but firm evidence are lacking. Here, we clearly showed that the recombinant proteins of Ly2.1–3 were capable of killing Gram-negative bacteria Aeromonas hydrophila and Escherichia coli, while they had little bactericidal activity against the Gram-positive bacteria Staphylococcus aureus and Bacillus subtilis . We also showed that recombinant proteins Ly2.1–3 (rLy2.1–3) were able to bind to the Gram-negative bacteria A. hydrophila, E. coli and the microbial signature molecule LPS, but not to the Gram-positive bacteria S. aureus and B. subtilis as well as the microbial signature molecule LTA. Moreover, the Scatchard analysis revealed that rLy2.1–3 could specifically bind to LPS. Finally, we found that Ly2.1–3 were not cytotoxic to mammalian cells. All these together indicate that Ly2.1–3 can function as AMPs.